Shivinder Singh Net Worth

Shivinder Singh was the CEO of Ranbaxy Laboratories until 2008 when he and his brother sold the company to Daiichi Sankyo for $4.6 billion. After the sale, Shivinder Singh and his brother invested heavily in a number of companies, including Fortis Healthcare, Religare, and a spiritual guru. Unfortunately, the investments did not pay off and the brothers were forced to declare bankruptcy in 2018. Shivinder Singh is an Indian businessman who was once worth $2.5 billion, but has since lost his fortune due to a series of bad investments and loans. He and his brother, Malvinder, were the heirs to the Ranbaxy Laboratory fortune created by their grandfather. In 2008, they sold the company to Daiichi Sankyo for $4.6 billion. After the sale, the brothers invested in a number of companies, but the investments did not pay off and they declared bankruptcy in 2018, leaving Shivinder Singh with a net worth of -$500 million.
Shivinder Singh is a member of Richest Billionaires

Age, Biography and Wiki

Birth Place India
Net Worth: -$250 Million
Gender: Male

💰 Net worth: -$250 Million (2024)

Some Shivinder Singh images

He was managing a director of Fortis Healthcare and the guiding force behind AIESEC India, the largest student directed organization in the world. His grandfather Bhai Mohan Singh founded Ranbaxy Laboratories. Shivinder and his brother Malvinder Mohan Singh inherited the family's 33.5% stake in Ranbaxy when their father passed away in 1999. They are both listed among the Top 20 richest Indians. Singh graduated with honors from St. Stephens College and he received an MBA from Duke University's Fuqua School of Business. The brothers sold their pharma inheritance in 2008 for $2 billion. They have also sold additional assets for hundreds of millions of dollars. Their newest venture is Air Mantra and the brothers are behind the largest student directed organization in the world, AIESEC India. Shivinder Singh is married and has three children. The brothers loaned a large amount of money to a guru. As of August 2018 they owe a $500 million fine for fraud in connection with the sale of their drug company in 2008. They are being sued of billions that were allegedly siphoned out of their financial company and healthcare company.